Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
Daré Bioscience’s CEO-led conference presentation is now available online for 90 days, with management also attending in-person investor meetings in mid-September.
Rhea-AI Summary
Daré Bioscience (DARE) announced that its pre-recorded presentation for the H.C. Wainwright 28th Annual Global Investment Conference is now available on-demand starting September 11, 2026, at 7:00 a.m. ET.
The presentation, led by President and CEO Sabrina Martucci Johnson, covers an overview of the company and recent corporate and clinical developments. It can be accessed via the conference link or through the Presentations, Events & Webcasts page in the Investors section of darebioscience.com and will remain available for 90 days. Management will also attend the conference in New York, NY, from September 14–16, 2026, for one-on-one investor meetings.
Positive
- None.
Negative
- None.
Key Figures
- Presentation availability
- September 11, 2026 at 7:00 a.m. ET
- On-demand conference presentation
AI-generated analysis. How Rhea-AI works. Not financial advice.
View the video webcast here
SAN DIEGO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that its pre-recorded presentation for the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here.
The presentation, featuring Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience, provides an overview of the Company as well as recent corporate and clinical developments.
The on-demand presentation is available for viewing beginning today, September 11, 2026, at 7:00 a.m. ET, and can also be accessed through the Presentations, Events & Webcasts page of the Investors section of the Company’s website (darebioscience.com). The presentation will be accessible for 90 days.
Management will be on-site at the conference, being held September 14–16, 2026, in New York, NY, for one-on-one meetings with investors. For more information, please visit the conference website.
ABOUT DARÉ BIOSCIENCE, INC.
Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré Bioscience advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré Bioscience is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré Bioscience is working to change that. Learn more at darebioscience.com.
Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com
Source: Daré Bioscience, Inc.
FAQ
How can investors access Daré Bioscience’s on-demand conference presentation?
The on-demand video webcast can be accessed via the conference link provided by H.C. Wainwright or through the Presentations, Events & Webcasts page in the Investors section of Daré Bioscience’s website at darebioscience.com.
During what dates will the Daré Bioscience presentation remain available on-demand?
The pre-recorded presentation is available for on-demand viewing beginning September 11, 2026, at 7:00 a.m. ET and will remain accessible for 90 days from that start date.
When and where is the H.C. Wainwright 28th Annual Global Investment Conference being held?
The conference is being held in New York, NY, from September 14–16, 2026. Daré Bioscience management will be on-site for one-on-one meetings with investors during those dates.
Who presents on behalf of Daré Bioscience in the conference webcast?
The presentation features Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience, providing an overview of the company and its recent corporate and clinical developments.